NCT06828575 Evaluation of the Success of Artificial Intelligence Models in Interpreting Arterial Waveform Analysis Data
| NCT ID | NCT06828575 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
| Condition | Hemodynamic Instability |
| Study Type | OBSERVATIONAL |
| Enrollment | 145 participants |
| Start Date | 2025-02-15 |
| Primary Completion | 2025-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 145 participants in total. It began in 2025-02-15 with a primary completion date of 2025-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to evaluate the ability of artificial intelligence (AI) models to interpret arterial waveform analysis data obtained from a hemodynamic monitoring system in adult patients undergoing elective surgery. The main questions it aims to answer are: Can AI models (ChatGPT-4 and Gemini 2.0) accurately detect hemodynamic abnormalities in arterial waveform data? How well do AI-generated diagnoses align with expert anesthesiologist assessments? Are AI-generated treatment recommendations clinically appropriate? Participants will: Undergo standard hemodynamic monitoring with an arterial waveform analysis device (MostCare). Have their anonymized hemodynamic data analyzed by AI models for abnormality detection, diagnosis suggestions, and treatment recommendations. Have AI-generated results reviewed and validated by experienced anesthesiologists. This study aims to assess whether AI models can serve as decision-support tools in perioperative and critical care settings by improving the interpretation of complex hemodynamic data, potentially enhancing patient safety, diagnostic accuracy, and clinical efficiency.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Undergoing elective surgery with arterial waveform monitoring as part of standard perioperative care * Hemodynamic data successfully recorded using the MostCare hemodynamic monitoring system * Able to provide informed consent to participate in the study Exclusion Criteria: * Incomplete or corrupted hemodynamic data (e.g., signal artifacts preventing reliable analysis) * Emergency surgery cases * Patients with severe arrhythmias or hemodynamic instability that might interfere with arterial waveform interpretation * Refusal to participate or withdrawal of consent * Patients with contraindications to arterial catheterization (e.g., coagulopathy, severe peripheral vascular disease)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06828575 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hemodynamic Instability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06828575 currently recruiting?
Yes, NCT06828575 is actively recruiting participants. Contact the research team at enginihsan@hotmail.com for enrollment information.
Where is the NCT06828575 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06828575 clinical trial?
NCT06828575 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital. The trial plans to enroll 145 participants.